Biostar Pharmaceuticals, Inc.
BSPM
BSPM was delisted on the 18th of September, 2018.
6 hedge funds and large institutions have $506K invested in Biostar Pharmaceuticals, Inc. in 2015 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 2 closing their positions.
25% less funds holding
Funds holding: 8 → 6 (-2)
38% less capital invested
Capital invested by funds: $816K → $506K (-$310K)
50% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 2
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$12.2K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NCCM
Nine Chapters Capital Management
Short Hills,
New Jersey
|
-$61K |
| 2 |
VKH
Virtu KCG Holdings
New York
|
-$13K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$3.9K |
| 4 |
Morgan Stanley
New York
|
-$22 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Renaissance Technologies
New York
| $485K | +$12.2K | +2,243 | +2% |
|
2
California Public Employees Retirement System
Sacramento,
California
| $10K | – | – | – |
|
|
ISB
3
Iowa State Bank
Urbandale,
Iowa
| $9K | – | – | – |
|
|
4
UBS Group
Zurich,
Switzerland
| $1K | -$3.9K | -716 | -87% |
|
5
Bank of America
Charlotte,
North Carolina
| $1K | – | – | – |
|
|
NCCM
6
Nine Chapters Capital Management
Short Hills,
New Jersey
| – | -$61K | -8,386 | Closed |
|
|
VKH
7
Virtu KCG Holdings
New York
| – | -$13K | -1,770 | Closed |
|
|
8
Morgan Stanley
New York
| – | -$22 | -4 | -14% |
|
BSPM Hedge Fund Activity: Q3 2015 in Review
6 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in Biostar Pharmaceuticals, Inc. (BSPM) for Q3 2015, worth a combined $506K — down 38% from $816K a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of BSPM and 0 opened new positions — a net loss of 2 holders — while 2 trimmed existing stakes and 1 added.
The largest buyer was Renaissance Technologies, adding an estimated $12.2K. The largest seller was Nine Chapters Capital Management, exiting entirely with an estimated $61K sold.
- 6 institutional investors held Biostar Pharmaceuticals, Inc. (BSPM) as of Q3 2015, down from 8 in Q2 2015.
- Funds reported $506K of Biostar Pharmaceuticals, Inc. stock for Q3 2015, down 38% quarter-over-quarter.
- 0 funds opened new Biostar Pharmaceuticals, Inc. positions in Q3 2015 and 2 closed out, a net change of -2 holders.
- The largest Biostar Pharmaceuticals, Inc. buyer in Q3 2015 was Renaissance Technologies, an estimated $12.2K added.
- The largest Biostar Pharmaceuticals, Inc. seller in Q3 2015 was Nine Chapters Capital Management, an estimated $61K sold.
Based on aggregated 13F filings for Q3 2015.